 |
|
||||||||||
|
Press ReleasesMarch 11, 2010Bilcare Research opens new GCS unit at Crickhowell
11 March 2010 (Wales, UK) - Bilcare Global Clinical Supplies, a leading single-source provider of clinical trial services spread across continents will open its second unit on The Elvicta Industrial Estate, Crickhowell, Wales, UK. The new unit will add 30,000 sq ft and double the company's European capacity to package, store and distribute clinical supplies in ambient, refrigerated and frozen conditions. Bilcare – a global company headquartered in India – established its Crickhowell site in 2006 when it purchased DHP. The Bilcare Global Clinical Supplies facility at Crickhowell is contributing to a nascent pharmaceutical “cluster” of companies in UK. Mr. Mohan Bhandari, Chairman & Managing Director, Bilcare Limited, said, “With the drug discovery program leading to potential new drugs becoming more complex, the need to clinically test drug efficacy and safety in diverse population groups across multiple geographic regions is becoming a crucial necessity. This necessity has lead Bilcare to expand and open new facilities in US, Europe and Asia. With this expansion of the second center at Crickhowell, we are now geared to cater to ever challenging requirements of our global customers, especially those part of the UK “cluster” of companies, looking to roll out their clinical trials effectively in Europe.” In conjunction with the expansion, Bilcare Research specializes in primary packaging for pharmaceutical products and security technology such as nonClonableID™. Based around modular architecture, nonClonableID™ enhances customer safety, improves supply chain efficiency, reduces inventory levels, and improves customer relationship management. Speaking on this new and innovative technology, Dr. Praful Naik, Chief Scientific Officer, Bilcare Limited, said, “This technology can help strengthen the secure pedigree of CTM globally across clinical sites and provide multiple business outcomes i.e. effective & authentic management of Returns, Reconciliation and Destruction.” Bilcare Global Clinical Supplies serves the Americas, Europe, and Asia with clinical trial materials support, services and complete project management. Our services for solid, semi-solid, liquid, DEA (CI-V) and biotech clinical trial materials (CTM) satisfy a broad range of requirements, from pre-formulation research and development, analytical services and clinical supplies packaging and labeling, to IVRS, controlled temperature (cold and frozen chain) CTM storage, distribution worldwide, and returns and destructions accountability. For more information about Bilcare Global Clinical Supplies, please visit our website at www.bilcaregcs.com Media Contacts:Ian Morgan Bilcare Research   |
|
| © , Bilcare Limited. All Rights Reserved. | Disclaimer Site Map Privacy Policy | Content + Design Riteverses |